DOCSLIB.ORG

High-Risk Medication Pocket Guide

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
High-Risk Medication Pocket Guide High-Risk Medication Pocket Guide Therapeutic Class High-Risk Medication Potential Risks Alternative Medication Option Antihistamines Brompheniramine, Carbinoxamine, Highly anticholinergic (can cause dry mouth, flushing, dry Allergies: Cetirizine, Fexofenadine, Loratadine, Chlorpheniramine, Clemastine, skin, confusion, or difficulty urinating); Sedation. Levocetirizine (as a single agent or as Cyproheptadine, Dexbrompheniramine, Anxiety: Buspirone, SSRIs (Fluoxetine, Paroxetine), part of a combination Dexchlorpheniramine, Diphenhydramine SNRIs (Venlafaxine, Cymbalta) product) - excludes (oral), Doxylamine, Hydroxyzine, OTC products Promethazine, Triprolidine Insomnia: Melatonin, low-dose Trazodone Anti-Infectives Nitrofurantoin (when cumulative day supply Potential for pulmonary toxicity or peripheral neuropathy Infection: Ciprofloxacin, Trimethoprim/ is >90 days during plan year) (numbness, tingling, or pain in the hands, feet, or toes. Sulfamethoxazole, Amoxicillin/Clavulanate, Muscle weakness. Cephalexin Difficulty walking and/or problems with balance or coordination). Antiparkinson Agents Benztropine (oral), Trihexyphenidyl Highly anticholinergic (can cause dry mouth, flushing, Parkinson Disease: Selegiline, dry skin, confusion, or difficulty urinating); Carbidopa/Levodopa, Ropinirole, Pramipexole, Not recommended for prevention of extrapyramidal Entacapone symptoms with antipsychotics due to potential Antipsychotic induced Extrapyramidal Symptoms: hallucinations. Quetiapine, Clozapine Antipsychotics Thioridazine Highly anticholinergic (can cause dry mouth, Behavioral problems in dementia: (conventional) flushing, dry skin, confusion, or difficulty urinating); Abilify, Olanzapine, Saphris, Haloperidol, Risk of extremely low blood pressure and heart rhythm Fanapt, Latuda, Invega, Quetiapine, Risperidone, changes. Ziprasidone Antithrombotics Dipyridamole (oral, short acting; does not May cause extremely low blood pressure; Platelet Aggregation: Aspirin, Clopidogrel apply to the extended-release combination More effective alternatives available. with aspirin), Ticlopidine Barbiturates Amobarbital, Butabarbital, Butalbital, High dependency rate; Risk of overdose at low dosages; Insomnia: Melatonin, low-dose Trazodone Pentobarbital, Phenobarbital, Secobarbital Increased risk of falling and confusion. Seizures: Divalproex, Levetiracetam, Lamotrigine, Carbamazepine Cardiovascular Agents Guanfacine, Methyldopa, Reserpine Increased risk of heart attack or stroke due Hypertension: ACE Inhibitors (Lisinopril, (>0.1mg/day), Nifedipine (immediate to rapid decrease in blood pressure. Ramipril), ARBs (Losartan), Beta Blockers release) (Atenolol, Metoprolol), Calcium Channel Blockers (Amlodipine), Thiazides (Hydrochlorothiazide) Digoxin (>0.125mg/day) Increased risk of toxicity with higher doses Heart Failure: ACE Inhibitors (Lisinopril, Ramipril), due to slow elimination from the body. Beta Blockers (Atenolol, Metoprolol) Disopyramide Highly anticholinergic (can cause dry mouth, flushing, dry Atrial Fibrillation: Beta Blockers skin, confusion, or difficulty urinating); May induce heart (Atenolol, Metoprolol), Calcium Channel Blockers failure in older adults. (Amlodipine) Central Nervous Chloral hydrate Increased risk of daytime sedation and falls. Insomnia: Melatonin, low-dose Trazodone System Meprobamate High dependency rate; Sedation. Anxiety: Buspirone, SSRIs (Fluoxetine, Paroxetine), SNRIs (Venlafaxine, Cymbalta) Endocrine Desiccated Thyroid Concerns about cardiac effects; Hypothyroidism: Levothyroxine safer alternatives available. Megestrol Concerns about cardiac effects; Weight Gain: Mirtazapine Avoid use due to minimal effect on weight gain. Estrogens Conjugated Estrogens (PREMARIN, Increased risk of Cardiovascular Disease (CVD) and cancer Osteoporosis: PREMPRO), Esterified Estrogens, in older adults. Calcium and Vitamin D, Alendronate, Evista (with or without Estradiol, Estrogen Patch progesterone; Hot flashes: SSRIs (Fluoxetine, Paroxetine), (VIVELLE-DOT), Estropipate oral and topical patch Gabapentin, Venlafaxine products only) Vaginal symptoms: Estrace Vaginal Cream, Premarin Vaginal Cream High-Risk Medication Pocket Guide Therapeutic Class High-Risk Medication Potential Risks Alternative Medication Option Gastrointestinal Trimethobenzamide Highly anticholinergic (can cause dry mouth, flushing, dry Nausea/Vomiting: Granisetron, Ondansetron, skin, confusion, or difficulty urinating); Sedation. Prochlorperazine Narcotic Analgesics Meperidine, Pentazocine CNS adverse effects leading to increased Mild to Moderate Pain: Acetaminophen, NSAIDs risk of toxicity; May cause confusion; (Ibuprofen), Capsaicin, Codeine/Acetaminophen, (Includes oral Safer alternatives available. Topical NSAIDs (Voltaren) and injectable routes only) Moderate to Severe Pain: Capsaicin, Hydrocodone/ Acetaminophen, Oxycodone/Acetaminophen Non-Benzodiazepine Eszopiclone (LUNESTA), Zaleplon (SONA- Increased risk of daytime sedation and falls. Insomnia: Melatonin, low-dose Trazodone Hypnotics TA), Zolpidem (AMBIEN) (when cumulative day supply for any of the listed HRMs is >90 days during plan year) Non-Narcotic Ketorolac, Indomethacin Increased risk of GI toxicity. Mild to Moderate Pain: Acetaminophen, NSAIDs Analgesics (Ibuprofen), Capsaicin, Codeine/Acetaminophen, Topical NSAIDs (Voltaren) (includes oral and injectable Moderate to Severe Pain: Capsaicin, Hydrocodone/ routes only) Acetaminophen, Oxycodone/Acetaminophen Skeletal Muscle Carisoprodol, Chlorzoxazone, Highly anticholinergic (can cause dry mouth, flushing, dry Pain/Muscle spasm: Baclofen, Tizanidine Relaxants Cyclobenzaprine, Metaxalone, skin, confusion, or difficulty urinating); Sedation leading to Methocarbamol, Orphenadrine extremely low blood pressure; Increased risk of falling. (as a single agent or as part of a combination product) Sulfonylureas Chlorpropramide, Glyburide Risk of prolonged hypoglycemia. Diabetes: Glimepiride, Glipizide (long-duration) Tertiary TCAs Amitriptyline, Clomipramine, Doxepin Highly anticholinergic (can cause dry mouth, flushing, dry Depression: Desipramine, Nortriptyline, low-dose (>6mg/day), Imipramine, Trimipramine skin, confusion, or difficulty urinating); Sedation; Increased Trazodone, SSRIs (Sertraline), SNRIs (Venlafaxine), (as a single risk of falling Mirtazapine, Bupropion agent or as part and confusion. Nerve Pain: Capsaicin, Desipramine, Nortriptyline, of a combination Cymbalta, Lyrica, Gabapentin, Lidoderm product) Insomnia: Melatonin, low-dose Trazodone Vasodilators Ergoloid Mesylates, Isoxsuprine Lack of efficacy. Platelet Aggregation: Aspirin, Clopidogrel Peripheral Vascular Disease: Cilostazol Dementia: Galantamine, Rivastigmine, Donepezil This list of high-risk medications is provided by Blue Cross and Blue Shield of Alabama as recommendations to improve medication management with elderly patients. It is not intended to substitute the clinical judgment of the attending physician. This is not a comprehensive list of alternative options. Please refer to the current formulary for other possible alternatives. An independent licensee of the Blue Cross and Blue Shield Association.
Load more

Recommended publications
  • XYZAL (Levocetirizine Dihydrochloride)
    HIGHLIGHTS OF PRESCRIBING INFORMATION • Patients with end-stage renal impairment at less than 10 mL/min These highlights do not include all the information needed to use XYZAL creatinine clearance or patients undergoing hemodialysis (2.3, 4) safely and effectively. See full prescribing information for XYZAL. • Children 6 to 11 years of age with renal impairment (2.3, 4) ® XYZAL (levocetirizine dihydrochloride) ------------------------WARNINGS AND PRECAUTIONS----------------------- 5 mg tablets 2.5 mg/5 mL (0.5 mg/mL) oral solution • Avoid engaging in hazardous occupations requiring complete mental Initial U.S. Approval: 1995 alertness such as driving or operating machinery when taking XYZAL (5.1). ---------------------------RECENT MAJOR CHANGES--------------------------- • Avoid concurrent use of alcohol or other central nervous system Dosage and Administration (2) 01/2008 depressants with XYZAL (5.1). Dosage and Administration, Adults & Children 12 Years & Older (2.1) 01/2008 ------------------------------ADVERSE REACTIONS------------------------------ Dosage and Administration, Children 6 to 11 Years (2.2) 01/2008 The most common adverse reactions (rate ≥2% and > placebo) were ---------------------------INDICATIONS AND USAGE---------------------------- somnolence, nasopharyngitis, fatigue, dry mouth, and pharyngitis in subjects XYZAL is a histamine H1-receptor antagonist indicated for: 12 years of age and older, and pyrexia, somnolence, cough, and epistaxis in • The relief of symptoms associated with seasonal and perennial allergic
    [Show full text]
  • New York State Medicaid Drug Utilization Review Board Meeting Agenda
    New York State Medicaid Drug Utilization Review Board Meeting Agenda The Drug Utilization Review (DUR) Board will meet on April 27, 2016, from 9:00 a.m. to 4:00 p.m., Meeting Room 6, Concourse, Empire State Plaza, Albany, New York Agenda Items A. Preferred Drug Program (PDP) The DUR Board will review therapeutic classes listed below, as they pertain to the PDP. The DUR Board will review clinical and financial information, to recommend preferred and non-preferred drugs. For therapeutic classes currently subject to the PDP^, the DUR Board will only consider clinical information which is new since the previous review of the therapeutic class and then consider financial information. New clinical information may include a new drug or drug product information, new indications, new safety information or new published clinical trials (comparative evidence is preferred, or placebo controlled when no head-to-head trials are available). Information in abstract form alone, posters, or unpublished data are poor quality evidence for the purpose of re-review and submission is discouraged. Those wishing to submit new clinical information must do so in an electronic format by April 12, 2016 or the Board may not have ample time to review the information. ^ The current preferred and non-preferred status of drugs subject to the Preferred Drug List (PDL) may be viewed at https://newyork.fhsc.com/downloads/providers/NYRx_PDP_PDL.pdf 1. Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) – Prescription (Previous review date: April 22, 2015) Anaprox DS (naproxen
    [Show full text]
  • Drugs to Avoid in Patients with Dementia
    Detail-Document #240510 -This Detail-Document accompanies the related article published in- PHARMACIST’S LETTER / PRESCRIBER’S LETTER May 2008 ~ Volume 24 ~ Number 240510 Drugs To Avoid in Patients with Dementia Elderly people with dementia often tolerate drugs less favorably than healthy older adults. Reasons include increased sensitivity to certain side effects, difficulty with adhering to drug regimens, and decreased ability to recognize and report adverse events. Elderly adults with dementia are also more prone than healthy older persons to develop drug-induced cognitive impairment.1 Medications with strong anticholinergic (AC) side effects, such as sedating antihistamines, are well- known for causing acute cognitive impairment in people with dementia.1-3 Anticholinergic-like effects, such as urinary retention and dry mouth, have also been identified in drugs not typically associated with major AC side effects (e.g., narcotics, benzodiazepines).3 These drugs are also important causes of acute confusional states. Factors that may determine whether a patient will develop cognitive impairment when exposed to ACs include: 1) total AC load (determined by number of AC drugs and dose of agents utilized), 2) baseline cognitive function, and 3) individual patient pharmacodynamic and pharmacokinetic features (e.g., renal/hepatic function).1 Evidence suggests that impairment of cholinergic transmission plays a key role in the development of Alzheimer’s dementia. Thus, the development of the cholinesterase inhibitors (CIs). When used appropriately, the CIs (donepezil [Aricept], rivastigmine [Exelon], and galantamine [Razadyne, Reminyl in Canada]) may slow the decline of cognitive and functional impairment in people with dementia. In order to achieve maximum therapeutic effect, they ideally should not be used in combination with ACs, agents known to have an opposing mechanism of action.1,2 Roe et al studied AC use in 836 elderly patients.1 Use of ACs was found to be greater in patients with probable dementia than healthy older adults (33% vs.
    [Show full text]
  • Tizanidine Brands: Zanaflex®
    Medication Information Sheet Tizanidine brands: Zanaflex® Medications are only ONE part of a successful treatment plan. They are appropriate when they provide benefit, improve function and have either no or mild, manageable side effects. Importantly, medications (even if natural) are chemical substances not expected in the body, and as such have side effects. Some of the side effects might be unknown. The use of medications/drugs for any purpose requires patient consent. This practice does NOT require a patient to use any medication. Information & potential benefits Tizanidine is a medication that helps with muscle spasms and musculoskeletal pain syndromes; there is evidence that it helps neuropathic and musculoskeletal pain through alpha‐2‐receptor activity. Studies have shown Zanaflex helpful for neuropathic pain and some types of headache. It is currently FDA approved for muscle spasticity. Potential risks and side effects Tizanidine should be used carefully in cases of liver or kidney disease, low blood pressure, or heart conduction problems (QT interval problems). It should not be used with Luvox or with the antibiotic Cipro (ciprofloxacin). There are many other drugs that can interact with Tizanadine. In addition to the standard side effects listed in the disclaimer, common side effects or Zanaflex include dry mouth, sleepiness, dizziness, asthenia, infection, constipation, urinary frequency, flu‐like feeling, low blood pressure, more spasms, sore throat and runny nose. More serious side effects include liver damage, severe slowing of the heart beat and hallucinations. Tizanidine occasionally causes liver injury. In controlled clinical studies, approximately 5% of patients treated with tizanidine had non‐serious elevations of liver function tests.
    [Show full text]
  • MEDICATIONS to AVOID PRIOR to ALLERGY SKIN TESTING Allergy
    MEDICATIONS TO AVOID PRIOR TO ALLERGY SKIN TESTING Allergy testing requires the ‘histamine response’ in order to be accurate and reliable. There are many types of antihistamines. Antihistamines are found in many different medicines, either as a single drug or mixed with a combination of chemicals. Please review all medicines you take (including Over-The-Counter) in order to make your allergy testing appointment most efficient and accurate. Generic names are in all lower case, trade names Capitalized. Oral antihistamines to be stopped 3 (THREE) days prior to your appointment: - brompheniramine (Actifed, Atrohist, Dimetapp, Drixoral) - cetirizine (Zyrtec, Zyrtec D) - chlopheniramine (Chlortrimeton, Deconamine, Kronofed A, Novafed A, Rynatan, Tussinex) - clemastine (Tavist, Antihist) - cyproheptadine (Periactin) - diphenhydramine (Benadryl, Allernix, Nytol) - doxylamine (Bendectin, Nyquil) - hydroxyzine (Atarax, Marax, Vistaril) - levocetirizine (Xyzal) - promethazine (Phenergan) Oral antihistamines to be stopped 7 (SEVEN) days prior to your appointment: - desloratadine (Clarinex) - fexofenadine (Allegra, Allegra D) - loratadine (Claritin, Claritin D, Alavert) Nose spray and eye drop antihistamines to stop 5 (FIVE) days prior to your appointment: - azelastine (Astelin, Astepro, Dymista, Optivar) - bepotastine (Bepreve) - ketotifen (Zaditor, Alaway) - olapatadine (Pataday, Patanase) - pheniramine (Visine A, Naphcon A) – OK to stop for 2 days Antacid medications (different type of antihistamine) to stop 3 (THREE) days prior to your appointment: - cimetidine (Tagamet) - famotidine (Pepcid) - ranitidine (Zantac) Note: Antihistamines are found in many over the counter medications, including Tylenol Allergy, Actifed Cold and Allergy, Alka-Seltzer Plus Cold with Cough Formula, and many others. Make sure you read and check the ingredients carefully and stop those containing antihistamines at least 3 (THREE) days prior to the appointment.
    [Show full text]
  • 667783-Atenolol (ACC-UK)06-16-SPC-PIL
    Artwork No. - Colours Used Customer Accord Pantone Black Description Atenolol Market UK Language English Size 170 x 550 mm PIL Min. Font Size 9.5 Version No. 13 (Page 1 of 2) (06-16-Atenolol SPC) Date 07_05_16 (Atenolol (ACC-UK)06-16-SPC-PIL) Prepared By Checked By Approved By Regulatory Affairs Regulatory Affairs Quality Assurance You must consult your doctor if you are If you forget to take Atenolol Tablets 6. Contents of the pack and other planning to combine Atenolol tablets with the If you forget to take a dose of the Atenolol information medicines listed below: Tablet, take it as soon as you remember, PACKAGE LEAFLET: INFORMATION FOR • Clonidine (for high blood pressure or unless it is time for your next dose. What Atenolol Tablet contains THE USER migraine). If you are taking clonidine and Do not take a double dose to make up for a • The active ingredient is Atenolol. Atenolol 25 mg Tablets Atenolol tablets together, do not stop taking forgotten dose. • The other ingredients are Heavy clonidine unless your doctor tells you to do Magnesium Carbonate, Maize Starch, Atenolol 50 mg Tablets so. If you have to stop taking clonidine, your If you stop taking Atenolol Tablets Sodium Lauryl Sulphate, Gelatin, doctor will give you careful instructions Do not stop taking Atenolol Tablets without Magnesium Stearate, Microcrystalline Atenolol 100 mg Tablets about how to do it. talking to your doctor. In some cases, you may Cellulose and Purified Talc. (Atenolol) • Verapamil, diltiazem and nifedipine (for high need to stop taking it gradually over 7-14 days blood pressure or chest pain).
    [Show full text]
  • Paper Clip—High Risk Medications
    You belong. PAPER CLIP—HIGH RISK MEDICATIONS Description: Some medications may be risky for people over 65 years of age and there may be safer drug choices to treat some conditions. It is recommended that medications are reviewed regularly with your providers/prescriber to ensure patient safety. Condition Treated Current Medication(s)-High Risk Safer Alternatives to Consider Urinary Tract Infections (UTIs), Nitrofurantoin Bactrim (sulfamethoxazole/trimethoprim) or recurrent UTIs, or Prophylaxis (Macrobid, or Macrodantin) Trimpex/Proloprim/Primsol (trimethoprim) Allergies Hydroxyzine (Vistaril, Atarax) Xyzal (Levocetirizine) Anxiety Hydroxyzine (Vistaril, Atarax) Buspar (Buspirone), Paxil (Paroxetine), Effexor (Venlafaxine) Parkinson’s Hydroxyzine (Vistaril, Atarax) Symmetrel (Amantadine), Sinemet (Carbidopa/levodopa), Selegiline (Eldepryl) Motion Sickness Hydroxyzine (Vistaril, Atarax) Antivert (Meclizine) Nausea & Vomiting Hydroxyzine (Vistaril, Atarax) Zofran (Ondansetron) Insomnia Hydroxyzine (Vistaril, Atarax) Ramelteon (Rozerem), Doxepin (Silenor) Chronic Insomnia Eszopiclone (Lunesta) Ramelteon (Rozerem), Doxepin (Silenor) Chronic Insomnia Zolpidem (Ambien) Ramelteon (Rozerem), Doxepin (Silenor) Chronic Insomnia Zaleplon (Sonata) Ramelteon (Rozerem), Doxepin (Silenor) Muscle Relaxants Cyclobenazprine (Flexeril, Amrix) NSAIDs (Ibuprofen, naproxen) or Hydrocodone Codeine Tramadol (Ultram) Baclofen (Lioresal) Tizanidine (Zanaflex) Migraine Prophylaxis Elavil (Amitriptyline) Propranolol (Inderal), Timolol (Blocadren), Topiramate (Topamax),
    [Show full text]
  • CT Myelogram Drugs to Avoid Hold for 48 Hours Before and 12 Hours After Your Myelogram UVA Neuroradiology
    CT Myelogram Drugs to Avoid Hold for 48 Hours Before and 12 Hours After Your Myelogram UVA Neuroradiology Generic Name (Brand Name) Cidofovir (Vistide) Acetaminophen/butalbital (Allzital; Citalopram (Celexa) Bupap) Clomipramine (Anafranil) Acetaminophen/butalbital/caffeine Clonidine (Catapres; Kapvay) (Fioricet; Butace) Clorazepate (Tranxene-T) Acetaminophen/butalbital/caffeine/ Clozapine (Clozaril; FazaClo; Versacloz) codeine (Fioricet with codeine) Cyclizine (No Brand Name) Acetaminophen/caffeine (Excedrin) Cyclobenzaprine (Flexeril) Acetaminophen/caffeine/dihydrocodeine Desipramine (Norpramine) (Panlor; Trezix) Desvenlafaxine (Pristiq; Khedezla) Acetaminophen/tramadol (Ultracet) Dexmethylphenidate (Focalin) Aliskiren (Tekturna) Dextroamphetamine (Dexedrine; Amitriptyline (Elavil) ProCentra; Zenzedi) Amitriptyline and chlordiazepoxide Dextroamphetamine and amphetamine (Limbril) (Adderall) Amoxapine (Asendin) Diazepam (Valium; Diastat) Aripiprazole (Abilify) Diethylpropion (No Brand Name) Armodafinil (Nuvigil) Dimenhydrinate (Dramamine) Asenapine (Saphris) Donepezil (Aricept) Aspirin/caffeine (BC Powder; Goody Doripenem (Doribax) Powder) Doxapram (Dopram) Atomoxetine (Strattera) Doxepin (Silenor) Baclofen (Gablofen; Lioresal) Droperidol (No Brand Name) Benzphetamine (Didrex; Regimex) Duloxetine (Cymbalta) Benztropine (Cogentin) Entacapone (Comtan) Bismuth Ergotamine and caffeine (Cafergot; subcitrate/metronidazole/tetracycline Migergot) (Pylera) Escitalopram (Lexapro) Bismuth subsalicylate (Pepto-Bismol) Fluoxetine (Prozac; Sarafem)
    [Show full text]
  • Guideline for Preoperative Medication Management
    Guideline: Preoperative Medication Management Guideline for Preoperative Medication Management Purpose of Guideline: To provide guidance to physicians, advanced practice providers (APPs), pharmacists, and nurses regarding medication management in the preoperative setting. Background: Appropriate perioperative medication management is essential to ensure positive surgical outcomes and prevent medication misadventures.1 Results from a prospective analysis of 1,025 patients admitted to a general surgical unit concluded that patients on at least one medication for a chronic disease are 2.7 times more likely to experience surgical complications compared with those not taking any medications. As the aging population requires more medication use and the availability of various nonprescription medications continues to increase, so does the risk of polypharmacy and the need for perioperative medication guidance.2 There are no well-designed trials to support evidence-based recommendations for perioperative medication management; however, general principles and best practice approaches are available. General considerations for perioperative medication management include a thorough medication history, understanding of the medication pharmacokinetics and potential for withdrawal symptoms, understanding the risks associated with the surgical procedure and the risks of medication discontinuation based on the intended indication. Clinical judgement must be exercised, especially if medication pharmacokinetics are not predictable or there are significant risks associated with inappropriate medication withdrawal (eg, tolerance) or continuation (eg, postsurgical infection).2 Clinical Assessment: Prior to instructing the patient on preoperative medication management, completion of a thorough medication history is recommended – including all information on prescription medications, over-the-counter medications, “as needed” medications, vitamins, supplements, and herbal medications. Allergies should also be verified and documented.
    [Show full text]
  • Antihistamines in the Treatment of Chronic Urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 a Del Cuvillo,6 J Mullol,7 J Sastre,8 a Valero5
    Antihistamines in the treatment of chronic urticaria I Jáuregui,1 M Ferrer,2 J Montoro,3 I Dávila,4 J Bartra,5 A del Cuvillo,6 J Mullol,7 J Sastre,8 A Valero5 1 Service of Allergy, Hospital de Basurto, Bilbao, Spain 2 Department of Allergology, Clínica Universitaria de Navarra, Pamplona, Spain 3 Allergy Unit, Hospital La Plana, Villarreal (Castellón), Spain 4 Service of Immunoallergy, Hospital Clínico, Salamanca, Spain 5 Allergy Unit, Service of Pneumology and Respiratory Allergy, Hospital Clínic (ICT), Barcelona, Spain 6 Clínica Dr. Lobatón, Cádiz, Spain 7 Rhinology Unit, ENT Service (ICEMEQ), Hospital Clínic, Barcelona, Spain 8 Service of Allergy, Fundación Jiménez Díaz, Madrid, Spain ■ Summary Chronic urticaria is highly prevalent in the general population, and while there are multiple treatments for the disorder, the results obtained are not completely satisfactory. The second-generation H1 antihistamines remain the symptomatic treatment option of choice. Depending on the different pharmacokinetics and H1 receptor affi nity of each drug substance, different concentrations in skin can be expected, together with different effi cacy in relation to the histamine-induced wheal inhibition test - though this does not necessarily have repercussions upon clinical response. The antiinfl ammatory properties of the H1 antihistamines could be of relevance in chronic urticaria, though it is not clear to what degree they infl uence the fi nal therapeutic result. Before moving on to another therapeutic level, the advisability of antihistamine dose escalation should be considered, involving increments even above those approved in the Summary of Product Characteristics. Physical urticaria, when manifesting isolatedly, tends to respond well to H1 antihistamines, with the exception of genuine solar urticaria and delayed pressure urticaria.
    [Show full text]
  • Pms-ATENOLOL Atenolol Tablets, BP 25 Mg, 50 Mg and 100 Mg
    - PRODUCT MONOGRAPH Pr pms-ATENOLOL Atenolol Tablets, BP 25 mg, 50 mg and 100 mg Beta-adrenergic receptor blocking agent PHARMASCIENCE INC. Date of Revision: 6111 Royalmount Ave., Suite 100 November 3, 2017 Montreal, Quebec H4P 2T4 www.pharmascience.com Submission Control No: 201217 PRODUCT MONOGRAPH NAME OF DRUG Prpms-ATENOLOL Atenolol Tablets, BP 25 mg, 50 mg and 100 mg THERAPEUTIC CLASSIFICATION Beta-adrenergic receptor blocking agent ACTIONS AND CLINICAL PHARMACOLOGY Atenolol is a beta1-selective, beta adrenergic blocking agent, devoid of membrane stabilizing or intrinsic sympathomimetic (partial agonist) activities. It is a racemic mixture and the beta1 properties reside in the S (-) enantiomer. Beta1-selectivity decreases with increasing dose. The mechanism of the antihypertensive effect has not been established. Among the factors that may be involved are: a) competitive ability to antagonize catecholamine-induced tachycardia at the beta-receptor sites in the heart, thus decreasing cardiac output b) inhibition of renin release by the kidneys c) inhibition of the vasomotor centres The mechanism of the anti-anginal effect is also uncertain. An important factor may be the reduction of myocardial oxygen requirements by blocking catecholamine-induced increases in heart rate, systolic blood pressure, and the velocity and extent of myocardial contraction. In man atenolol reduces both isoproterenol- and exercise-induced increases in heart rate over the dose range of 50 to 200 mg. At an oral dose of 100 mg the beta1 blocking effects persist for at least 24 hours; the reduction in exercise-induced heart rate increase being about 32% and 13%, 2 and 24 hours after dosing, respectively.
    [Show full text]
  • Use of Amitriptyline for the Treatment of Chronic Tension-Type Headache
    Med Oral Patol Oral Cir Bucal. 2008 Sep1;13(9):E567-72. Amitriptyline and chronic tension-type headache Med Oral Patol Oral Cir Bucal. 2008 Sep1;13(9):E567-72. Amitriptyline and chronic tension-type headache Publication Types: Review Use of amitriptyline for the treatment of chronic tension-type headache. Review of the literature Eulalia Torrente Castells 1, Eduardo Vázquez Delgado 2, Cosme Gay Escoda 3 (1) Odontóloga. Residente del Máster de Cirugía Bucal e Implantología Bucofacial. Facultad de Odontología de la Universidad de Barcelona (2) Odontólogo. Profesor Asociado de Cirugía Bucal. Profesor responsable de la Unidad de Patología de la ATM y Dolor Bucofacial del Máster de Cirugía Bucal e Implantología Bucofacial. Facultad de Odontología de la Universidad de Barcelona. Especialista de la Unidad de Patología de la ATM y Dolor Bucofacial del Centro Médico Teknon. Barcelona (3) Médico-Estomatólogo y Cirujano Maxilofacial. Catedrático de Patología Quirúrgica Bucal y Maxilofacial. Director del Máster de Cirugía Bucal e Implantología Bucofacial. Facultad de Odontología de la Universidad de Barcelona. Co-director de la Unidad de Patología de la ATM y Dolor Bucofacial del Centro Médico Teknon. Barcelona Correspondence: Prof. Cosme Gay Escoda Centro Médico Teknon C/Vilana nº 12 08022 Barcelona E-mail: [email protected] Torrente-Castells E, Vázquez-Delgado E, Gay-Escoda C. Use of amitrip- Received: 28/09/2007 tyline for the treatment of chronic tension-type headache. Review of the Accepted: 11/07/2008 literature. Med Oral Patol Oral Cir Bucal. 2008 Sep1;13(9):E567-72. © Medicina Oral S. L. C.I.F. B 96689336 - ISSN 1698-6946 Indexed in: http://www.medicinaoral.com/medoralfree01/v13i9/medoralv13i9p567.pdf -Index Medicus / MEDLINE / PubMed -EMBASE, Excerpta Medica -SCOPUS -Indice Médico Español -IBECS Abstract Amitriptyline is a tricyclic antidepressant, considered the treatment of choice for different types of chronic pain, including chronic myofascial pain.
    [Show full text]